Exenatide improves glycaemic control and body weight but has important side effects

A syringe

Exenatide is an injectable incretin-based drug treatment for type 2 diabetes belonging to the the class of glucagon-like peptide-1 (GLP-1) agonists.  One of its benefits is that it reduces body weight as well as glycaemia. NICE currently recommends exenatide as an add-on therapy where oral agents are not tolerated or ineffective.  This systematic review sought [read the full story…]